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Much of our current understanding of cell-mediated immunity to intracellular
pathogens stems from studies on the immune response to the bacterial pathogen
Listeria monocytogenes (1). It is generally believed that L. monocytogenes grows in resi-
dent macrophages but is killed by activated or inflammatory macrophages that mi-
grate from the bone marrow to the sites of infection (1).
Although the immune response to L. monocytogenes has received a great deal of
attention, until recently, little was known about the cell biology of intracellular growth.
However, the stages observed during the growth and spread of L. monocytogenes in
a macrophage cell line have recently been documented (4). It is now clear that
L. monocytogenes escapes from the host phagosome, exploits the host cytoskeletal ma-
chinery, and is presented in a pseudopod-like structure that is apparently recognized
and phagocytosed by a neighboring cell. These studies have provided a cell-biological
explanation for the absolute requirement for cell-mediated immunity to L. monocytogenes
infection in mice, i.e., the bacteria never leave the host cytoplasm yet are able to
spread cell to cell. It should now be possible to address the precise site(s) at which
anti-L. monocytogenes immunity is expressed in activated macrophages.
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Bacterial Strains and Growth Conditions.
￿
L. monocytogenes strain 104035 and the isogenic
hemolysin-negative mutant DP-L215 were the only strains used in this study and were grown
as previously described (5).
Cytokines.
￿
Murine rIFN-.y was a gift provided by Genentech (South San Francisco, CA)
at a concentration of 2 .4 mg/ml and a sp act of 1.9 x 10' U/ml. Murine rTNFa (Genen-
tech) was supplied at a concentration of 0.96 mg/ml and a sp act of 2.9 x 107 U/ml.
Tissue Culture.
￿
Primary cultures ofresident peritoneal macrophages were established from
specific pathogen-free female CD-1, ICR mice (Charles River Breeding Laboratories, Inc.,
Wilmington, MA), as previously described (6). Resident peritoneal exudate cells (2 x 107)
were deposited onto 12-mm round cover slips placed in 60 x 20-mm petri dishes in 5 ml
DME (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS. After 2 h, nonad-
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herent cellswere removed by gently washing with 37°C PBS, pH 7.4, and incubated in the
appropriate medium for 40 h.
Fate ofL. monocytogenes in Murine Macrophages.
￿
L. monocytogenes was prepared as previously
described (5). Monolayers of peritoneal macrophages grown on cover slips were infected with
2 x 106 bacteria/ml for 30 min. For the 30-min time point, cover slips were washed (by dip-
ping five times in 4°C PBS) and deposited, in triplicate, into 5 ml of sterile distilled water
in 15-ml conical tubes. After mixing vigorously for 15 s to lyse the infected cells, dilutions
were plated on BHI agar. This time point represents cell-associated bacteria and does not
discriminate between intracellular bacteria and those merely attached, although a vastmajority
ofthe cell-associated bacteria were intracellular (5, and data not shown). The remaining cover
slipswere washed three times with 37°C PBS followed by the addition of 5 ml ofprewarmed
medium. After 30 min, gentamicin sulfate was added to a final concentration of 5 pg/ml.
Gentamicin is added to kill any free bacteria that had not entered a macrophage. After 1 h,
and at each time point thereafter, the number of intracellular bacteria per cover slip was de-
termined as described above, but without washing in PBS. The data presented in Fig. 1 rep-
resent an average of three coverslips. It should be noted that the omission of gentamicin for
the first 4 h does not affect the results (5, and data not shown).
EM
￿
Peritoneal macrophages were deposited onto 35 x 10-mmtissue culture petri dishes
(Costar, Cambridge, MA) and incubated in the appropriate medium for 40 h. Monolayers
of peritoneal macrophages were infected as described above, but with 2 x 10' bacteria/ml.
After 4 h, the monolayerswere fixed in situ and prepared for EM as previously described (4).
Results and Discussion
Growth of L. monocytogenes in resident peritoneal macrophages was not nearly as
extensive as was previously seen in a macrophage-like cell line (8). In fact, -807o
of the bacteria associated with the macrophage monolayer after 30 min were killed
during the subsequent 90 min, and the survivors only doubled between two and
three times (Fig. 1 A). It is not clear why primary peritoneal cells restrict intracel-
lular growth of bacteria, but it may reflect the physiological state of the host cell,
as CSF1-treated or LPS-treated macrophages are more permissive for intracellular
growth than untreated cells (datanot shown). In contrast to peritoneal macrophages
incubated in medium alone, peritoneal macrophages incubated with rIFN-y com-
pletely suppressed any measurable bacterial growth, and continued to exhibit bacte-
ricidal activity for the duration of the experiment (Fig. 1 A). This activity was ob-
served with doses of rIFN-y as low as 1 u/ml (data not shown). Thus, rIFN-y has
a clear and measurable effect on the fate of intracellular L. monocytogenes. rTNF had
no measurable activity by itself, but in combination with rIFN-y, there was enhanced
bactericidal activity (Fig. 1 A).
It is clear that rINFy-treated peritoneal macrophages restrict the growth ofintra-
cellular L. monocytogenesand continue to exhibit bactericidal activity for the duration
of the 8-h experiment. However, it is curious that rINFy-treated macrophages exhibit
no more bactericidal activity than untreated cells during the first 2 h of infection,
a result that was similar to that reported by other investigators (2, 3). Therefore,
to directly examine bactericidal activity without error introduced from competition
of bacterial growth, we used a hemolysin-negative mutant (hly-) of L. monocytogenes.
This mutant is internalized by macrophages to the same degree as the hly' strain,
but is absolutely defective for intracellular growth (5). Thus, we can directly mea-
sure bactericidal activity using this strain. The results clearly showed that therewas
no difference in the fate of the hly- mutant in either untreated or rIFN-'r-treated
macrophages (Fig. 1 B). In both cases, the degree of killing resembled that of thePORTNOY ET AL.
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FIGURE 1.
￿
(A)Fate ofL. monocytogenes in mouseperitoneal macrophages treated with cytokines.
(Squares) Macrophages incubated with medium alone; (diamonds) macrophages incubated with
mouserTNFa(1,000 U/ml); (closedtriangles) macrophages incubatedwith rIFN-.y (100 U/ml; and
(open triangles) macrophages incubated with rIFN-y (100 U/ml) plus rTNFa (1,000 U/ml). (B)
Fate ofhemolysin-negative L. monocytogenes in mouseperitoneal macrophages treatedwith medium
alone or rIFN-,y (100 U/ml).
hly+ strain in rIFN-y-treated cells (Fig. 1 A). Thus, rIFN-'y does not only enhance
bactericidal activity, but somehow causes thehly+ strain to resemble the hly- strain.
Since it is now clear that hly+ L. monocytogenes grows in the host cytoplasm while
the hly- strain is restricted to the endosomal compartment (4, 7), IFN-y may pre-
vent access of the hly+ strain to the cell cytoplasm. Alternatively, rIFN-y may pre-
vent growth of L. monocytogenes in the cytoplasm. To differentiate between these two
possibilities, we used EM to examine the intracellular location of the hly+ strain
in the two macrophage populations.
Monolayers ofperitoneal macrophages were infected with L. monocytogenesfor 4 h,
then fixed, sectioned, and examined by EM. Recall, that even in untreated resident
macrophages, the majority of the bacteria are killed, and are therefore expected to
reside in phagocytic vacuoles. Accordingly, 72 % ofthe bacteria in theuntreatedmac-
rophage population were found in phagocytic vacuoles (Fig. 2 a and Table I). The
other 28% of the bacteria were clearly free in the cytoplasm and half of these were
surrounded by actin filaments (Fig. 2, 6 and c). In a previous study usinga macro-
phage cell line (4), we showed that association with actin filaments is required for
cell-to-cell spread ofthe bacteria. Now, we show that this occurs in primary macro-
phages as well. Based on our previous work, we hypothesize that bacteria that have
associated with actin filaments are probably viable and capable of spreading to an
adjacent cell. In the rIFN-y-treated macrophages, the vast majority of the bacteria
were in vacuoles (Fig. 2, d andf), while only 5% were free in the cytoplasm, and
none of these were surrounded by actin filaments (Fig. 2 e). Since the threebacteria
found in the cytoplasm were free of actin filaments, they were either nonviable, or
ifviable, probably incapable of cell-to-cell spread. In addition, therewere 171 "dots"
seen in the rIFN-y-treated population and none in the untreated population (Fig.2144
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FIGURE 2 .
￿
Electron micrographs of peritoneal macrophages infected with L . monocytogencs for
4 h . (a-c) Macrophages incubated in medium alone ; (d-g) macrophages incubated in rIFN--y
(100 Ulml) (bar = 0.1 A) . (a)L . monocytogenes present in aphagosome (x33,000) . (b)L . monocytogenes
in the process of division has entered the cytoplasm and is surrounded by acloud of actin fila-
ments (x 33,000). (c) L. monocytogenes has entered the cytoplasm and has reorganized the actin
filaments into an asymmetric tail as a prerequisite to spreading to aneighboring cell (x23,000) .
(d)L. monocytogenes present in a phagosome of an rIFN-1-treated cell (x 32,000) . (e) A rare in-
stance in which L. monocytogenes is found in the cytoplasm of an rIFN- ,y-treated macrophage.
Notice that the bacteria are not surrounded by actin filaments(x63,000). (f)L . monocytogenes present
in aphagosome in which the bacterium appears sick, probably in the early stage of degradation
(x33,000). (g) An electron-dense "dot" that may be the remains of an incompletely digested
L . monocytogenes (x47,000) .PORTNOY ET AL.
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TABLE I
Intracellular Location ofL. monocytogenes in
Resident and IFN-y-treated Peritoneal Macrophages
Bacteria in
￿
Bacteria
￿
Bacteria in
Treatment'
￿
Bacteria:
￿
endosome
￿
in cytoplasm
￿
cytoplasm and actins
Medium alone
￿
50
￿
36 (72)
￿
14(28)
￿
7 (14)
IFN-y
￿
59
￿
56(95)
￿
3 (5)
￿
0
' Mouseperitoneal macrophages were either treated with 100U/ml of IFN-y
for 40 h or in medium alone.
: The total number of intact bacteria observed by EM in one section .
S The densematerial surrounding the bacteria was previously identified as F-
actin by S1 decoration (4).
2 g). These dots are electron-dense structures that probably represent digested
L. monocytogenes, since they were not seen in uninfected rIFN-y-treated macrophages
(datanot shown). If so, this wouldreduce thepercentage ofbacteria in the cytoplasm
to 1.3%, compared with 28% for the control. Another striking difference between
the two populations was seen in the morphology of the bacteria. In the untreated
population, the majority of the bacteria in vacuoles appeared normal (Fig. 2 a). In
contrast, in the rIFN-,y-treated population, the majority of the bacteria appeared
"sick" and often showed a separation of the bacterial wall and plasma membrane
(Fig. 2J). ). Also, therewere substantial amounts ofmembranous material surrounding
the bacteria. These data suggest that rIFN-.y-treated macrophages have enhanced
ability to digest killed bacteria. This may be partially responsible for enhanced
L. monocytogenes antigen presentation in IFN--y-treated macrophages (8).
Thereareanumber ofstages in thegrowth and spread ofL. monocytogenesin which
primary macrophages halt the infection. First, even untreated resident peritoneal
macrophagesshow bactericidal activity and restrict subsequent intracellular growth
ofL. monocytogenes compared with a macrophage cell line or primary fibroblasts (5).
In addition, theresults ofourstudy areconsistent with an effect ofIFN-y in preventing
access ofthe bacteria to the cytoplasmiccompartment, therebyenhancingthe killing
of the bacteria in the phagolysosome. This is a critical step in pathogenicity, since
once L. monocytogenesenters the cytoplasmic compartment, the infection can spread
to adjacent, permissive cells, such as parenchymal cells in the liver and spleen (13).
How might IFN-y prevent access of L. monocytogenes to the cytoplasm? The most
obvious mechanism would be to block the action of hemolysin, which is thought
to mediate disruption of thephagosomal membrane (4, 7). Sincethe hemolysin con-
tains a unique, oxygen-labile cysteine (10), it is possible that reactive oxygen inter-
mediates or reactive nitrogen intermediates could render the hemolysin impotent.
Interestingly, the production of both reactive oxygen intermediates and reactive
nitrogen intermediates is stimulated by IFN-y and thought to play a role in micro-
biocidal and tumoricidal activity (11).
Summary
The effect of rIFN-y and rTNF on the fate of hemolytic and nonhemolytic (hly-)
Listeria monocytogenesin cultured mouse peritoneal macrophages was investigated. In2146
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untreated macrophages, -80% of the hemolytic bacteria were killed during the first
2 h of incubation, but the survivors doubled between two and three times. In rIFN-
,y-treated macrophages, although the bacterial killing was identical to the controls
during the first 2 h, there was no subsequent bacterial growth, and bactericidal ac-
tivity continued for the duration of the experiment. rTNF has no affect by itself,
but acted synergistically with rIFN-y to promote bacterial killing. Infected macro-
phages with or without rIFN-y were examined by EM. The results clearly showed
that the role of rIFN-y was to prevent access of L. monocytogenes to the macrophage
cytoplasm, which would prevent cell-to-cell spread ofthe bacteria. In addition, rIFN-
y-treated macrophages exhibited enhanced digestive capacity of the intracellular
bacteria.
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